Loading chat...
MN HF1320
Bill
Status
5/7/2010
Primary Sponsor
Frank Hornstein
Click for details
AI Summary
-
The Board of Pharmacy must adopt rules regarding drug substitution for epilepsy and seizure treatment if the FDA determines substitution poses a health risk to patients, following FDA interchangeability standards.
-
Any Board rule on epilepsy or seizure drug substitution that conflicts with Minnesota Statutes section 151.21, subdivision 3, shall supersede that conflicting statute.
-
If a proposed rule would increase state costs for public health care programs, the Board must report the proposed rule and associated increased costs to legislative leadership before adoption.
-
Amends Minnesota Statutes 2008, section 151.06, subdivision 1, to add these substitution rule requirements to the Board of Pharmacy's powers and duties.
Legislative Description
Board of Pharmacy required to adopt rules regarding the substitution of drugs used for the treatment of epilepsy or seizure if the United States Food and Drug Administration determines that substitution may cause a health risk to patients.
Last Action
Secretary of State Chapter 289 04/30/10
5/7/2010